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Abstract
Computational predictions of the functional impact of genetic variation play a critical role in human genetics research. For
nonsynonymous coding variants, most prediction algorithms make use of patterns of amino acid substitutions observed
among homologous proteins at a given site. In particular, substitutions observed in orthologous proteins from other species
are often assumed to be tolerated in the human protein as well. We examined this assumption by evaluating a panel of
nonsynonymous mutants of a prototypical human enzyme, methylenetetrahydrofolate reductase (MTHFR), in a yeast cell-
based functional assay. As expected, substitutions in human MTHFR at sites that are well-conserved across distant orthologs
result in an impaired enzyme, while substitutions present in recently diverged sequences (including a 9-site mutant that
‘‘resurrects’’ the human-macaque ancestor) result in a functional enzyme. We also interrogated 30 sites with varying degrees
of conservation by creating substitutions in the human enzyme that are accepted in at least one ortholog of MTHFR. Quite
surprisingly, most of these substitutions were deleterious to the human enzyme. The results suggest that selective
constraints vary between phylogenetic lineages such that inclusion of distant orthologs to infer selective pressures on the
human enzyme may be misleading. We propose that homologous proteins are best used to reconstruct ancestral sequences
and infer amino acid conservation among only direct lineal ancestors of a particular protein. We show that such an
‘‘ancestral site preservation’’ measure outperforms other prediction methods, not only in our selected set for MTHFR, but
also in an exhaustive set of E. coli LacI mutants.
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Introduction
Due to continuing advances in DNA sequencing technologies,
our knowledge of human genetic variation is rapidly increasing. It
is currently impractical to assay the biological effect of most
genetic variants empirically, so computational predictions of their
functional impact must play an important role in identifying
potential genetic causes underlying human disease. Here, we focus
on genetic variation that results in a single amino acid, or
nonsynonymous, substitution in an encoded protein. Nonsynon-
ymous changes comprise only a small fraction of known genetic
variation, yet account for a disproportionately large fraction of
known disease-causing variation in humans [1,2].
It has long been recognized that amino acid substitutions that
impair the function of a protein tend to involve substitution with
a chemically very different amino acid [3,4]. This is not
surprising, as relatively few of the amino acids (e.g. active site
amino acids of enzymes) in a protein are absolutely required for
function. Most positions contribute to stabilizing the requisite
structure of the active site and other binding and interaction sites,
and such sites tend to be more tolerant of physico-chemically
similar amino acid changes. As a result, some algorithms for
predicting the functional effect of amino acid substitutions make
use of measures of amino acid physico-chemical similarity.
Multiple scales of physico-chemical similarity have been devel-
oped. The first, developed by Grantham [5], assigns to each
possible amino acid substitution a similarity score that summa-
rizes several physico-chemical properties of the two amino acid
monomers. Grantham scores are site-independent (i.e. the
substitution of a valine for an isoleucine is given the same score,
regardless of the protein, or the site within the protein, in which
the substitution occurs). However, it has been demonstrated that
different sites vary greatly with respect to their tolerance to
substitution. Miller and Kumar [4] demonstrated that human
disease mutations have a strong statistical tendency to occur at
evolutionarily conserved (i.e. slowly evolving) sites. Chasman and
Adams [6] showed that mutation tolerance depends on several
properties of the local 3D structure of the site, and this
information has also been used to make site-specific predictions
of the functional effects of substitutions [6,7]. Such approaches
are limited to proteins of known three-dimensional structure, or
whose structure can be modeled based on a related protein.
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specific predictions that are based on patterns of evolutionary
substitution and that do not depend on structural information
[8–12]. Given enough homologs, there is often considerable
information about which substitutions have been ‘‘accepted’’ at a
given site across the homologous proteins [13]. If a substitution
was accepted (i.e. attained a high frequency in a population), the
substitution had no appreciable negative impact on the fitness of
the organism that harbored it, and therefore probably did not
negatively impact protein function. The implicit assumption in
deriving predictions based on this information is that accepted
substitutions in one protein would also be accepted in its
homologs; i.e. all homologs are assumed to be evolving under
the same selective constraints. This assumption has recently been
questioned for paralogous genes (genes that diverged by a gene
duplication event presumably followed by some degree of
functional divergence), and several groups have improved
predictions by restricting analysis to orthologs, rather than
paralogs [11,14,15]. However, it is not known to what extent
orthologous genes share selective constraints, particularly after
they have diverged substantially. In this paper, we test the utility of
orthologs in the prediction of the functional effects of substitutions
in the prototypical human enzyme methylenetetrahydrofolate
reductase (MTHFR), which catalyzes a critical step necessary for
the remethylation of homocysteine to methionine [16,17].
We selected MTHFR as a model for testing these assumptions
for several reasons. From a phenotypic standpoint, even mild
defects in MTHFR can lead to metabolic imbalances that increase
disease risk and thus would be subject to selective pressures. For
example, a common polymorphism (677CRT) that changes an
alanine at position 222 to a valine (referred to as A222V hereafter;
[18]) impairs enzyme activity by 50% and leads to elevated plasma
homocysteine levels in individuals with inadequate folate intakes
[16–18]. Homocysteine may be a risk factor for several common
diseases including cardiovascular disease [19] and neural tube
defects [20]. From an evolutionary standpoint, MTHFR was
present in the Last Universal Common Ancestor (LUCA) of all
extant life, and has been recognizably conserved in nearly every
organism sequenced to date. Since there appear to have been few
gene duplications, the gene is present in single copy in nearly all
animals, making these homologous genes unambiguous orthologs.
Finally, a robust yeast complementation assay has been developed,
allowing us to experimentally test the function of variants of
MTHFR [21].
In addition, from MTHFR resequencing studies in random
populations, we and others [21,22] have identified many novel,
low frequency nonsynonymous variants that affect enzyme
function. Significantly, like the common A222V variant, many
of these are remedial by folate supplementation [21]. As the pace
of genetic discovery rapidly increases, there will surely be many
novel MTHFR enzyme variants identified. Given the metabolic
significance of MTHFR and the ability to nutritionally correct
defective alleles, it would be desirable to predict in silico the
functional impact of nonsynonymous mutation rather than
empirically determine the effect of each variant individually.
Furthermore, using MTHFR as a model enzyme may illustrate
more general rules for computationally predicting the impact of
amino acid substitution on protein function.
To this end, we constructed 35 MTHFR enzyme variants (34 of
which differ from the major allele by a single amino acid and one
represents a reconstruction of the human-macaque ancestral allele
by a 9-site change) and tested them in a cell-based functional assay
based on complementation in the yeast Saccharomyces cerevisiae [21].
Specifically, we targeted sites that have been conserved to varying
degrees, and at these sites we created substitutions that have been
accepted in at least one known ortholog of human MTHFR. We
found, somewhat surprisingly, that most of our selected mutants of
MTHFR were not tolerated in the human enzyme despite their
presence in orthologous enzymes. These data suggested that the
orthologous genes are evolving under different evolutionary
constraints than human MTHFR. To remove potentially spurious
signals from substitutions accepted in orthologs after their
divergence from the human lineage, we subsequently restricted
our analysis to only direct lineal ancestors of human MTHFR.
Thus, we classified each site by its conservation only in direct
ancestors of the human enzyme, which we refer to as
‘‘preservation’’ among ancestors to distinguish it from the common
usage of ‘‘conservation’’ among homologs. The results indicated
that the extent to which sites are preserved in lineal ancestors was
a good predictor for whether that position was tolerable to change,
not only for human MTHFR but also in the LacI protein from
E. coli.
Methods
Quantitative Yeast Complementation Assay for MTHFR
Function
The specific aspects of the assay have been described previously
[21]. Briefly, a yeast strain was deleted for both the endogenous
MTHFR (MET13, necessary for methionine synthesis) and for a
folate biosynthetic enzyme (FOL3, dihydrofolate synthetase). The
resulting strain (met13::KanMX fol3::KanMX) requires folate supple-
mentation in the media and expression of a functional human
MTHFR for growth in absence of methionine. Under the
conditions of the assay, the rate at which the cells grow reflects
the cellular activity of the MTHFR variant interrogated [21,23]
for any given level of folate supplementation. Following transfor-
mation of the parent strain by each individual variant, growth in
the absence of methionine was recorded by optical density (OD595)
measured over time in low-volume cultures supplemented with
25 ug/ml folinic acid [21]. To assign a growth-rate metric for
quantitative comparisons between alleles, absorbance values were
Author Summary
The rapid pace of technological advances in DNA
sequencing methods is leading to the discovery of genetic
variants at a remarkable rate. Indeed, it is conceivable that
entire individual genomes will be sequenced routinely in
the near future. While these platforms greatly increase our
ability to catalog variation, they are also creating a
downstream need to efficiently process and filter this
information to ultimately identify genetic causes underly-
ing human disease. Since empirical evaluation of the
biological effects of mutation is not practical at such a
scale, computational methods that predict such effects are
needed. In this paper, we describe a novel methodology to
predict whether mutations that lead to amino acid
substitutions in proteins will impact protein function
and, therefore, may be more likely to have physiological
consequences. Specifically, we use orthologous proteins to
reconstruct the likely sequences of ancestral proteins in
the human lineage. We found that the longer a position
has been preserved from direct ancestors in the lineage
leading to the human enzyme, the more likely that
mutation at that site will have a deleterious effect. We
demonstrated that the method should be generally
applicable to all proteins.
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represented the maximal rate of cell growth (see Figure 1).
Although this metric was not a cell doubling rate per se, slope
calculations were easier to integrate into data handling, and
relative differences between variants were exactly the same as they
would be for doubling rates. All variants were tested in two or
more experiments involving at least 5 replicates per experiment.
Construction of Enzyme Variants
The yeast plasmid driving expression of human MTHFR
variants under the inducible GAL1 promoter has been described
previously [21,23]. This plasmid served as the backbone to
reconstruct all MTHFR variants by site-directed mutagenesis
using QuikChange kits (Stratagene). All variants were verified by
sequencing the entire coding region of MTHFR.
Defining Functional Versus Impaired Alleles
Replicate data sets for each substitution variant were compared
against a positive control (major MTHFR allele) and a known
impaired variant (A222V allele) as a negative control, using two
different statistical criteria to evaluate whether variants were
significantly different from either control. Significance was
determined against each control using both a Student’s t-test with
a Bonferroni-corrected p-value (p,0.0014 for 35 pairwise
comparisons) or Dunnett’s test for comparing multiple treatments
against a single control (alpha,0.01; [24]). Variants whose activity
was not significantly different from the major allele and
significantly better than the A222V allele by both statistical measures
were classified as functional, whereas variants whose activity was
significantly less than the major allele and not significantly better
than the negative control were classified as impaired. In the cases
where there was not a consensus in the comparisons, these alleles
were classified as equivocal. In this way, of the 36 alleles tested in
this study (including wild-type human MTHFR), 7 were classified
as functional, 25 were classified as impaired and 4 were equivocal
(see Figure 2). It should be noted that other statistical
determinations of functionality are possible, but they do not
appreciably change the results. For example, replacing Dunnett’s
test with False Discovery Rate analysis (q,0.01; [25]) results in the
same classifications for 34 of the 36 alleles.
Alignment of Orthologs, Phylogenetic Trees, and
Ancestral Sequence Determination
Human MTHFR. The alignment and phylogenetic tree were
from the PANTHER database [10], in which orthologs of human
MTHFR were aligned using MAFFT [26], and a phylogenetic
tree was constructed using the GIGA software (Thomas,
submitted), which use s known species relationships to help infer
the tree topology. Ancestral sequences were reconstructed for
human MTHFR using the PAML software package (version 4.2;
[27]) with the default parameter file for the aaml program (this
uses the WAG empirical model to estimate amino acid substitution
probabilities). For calculating ancestral site preservation (see
below), we considered a site to have a ‘‘known’’ ancestral amino
acid if the reconstruction probability exceeded 90%.
To more accurately reconstruct the human-macaque common
ancestral sequence, we used the actual nucleotide coding
sequences rather than the protein translation. We identified the
predicted coding nucleotide sequences for MTHFR from the
following Ensembl genomes: human, gorilla, orangutan, macaque,
and mouse lemur. The sequences were aligned using MAFFT
(with minor manual adjustment where necessary to maintain
codon alignment), and the phylogenetic tree was assumed to
match the species tree. Ancestral sequences were reconstructed
using the codeml program from PAML with default parameters.
This analysis does not use an empirical amino acid substitution
model, but rather distinguishes between nucleotide transitions and
transversions, and synonymous and nonsynonymous substitutions
with a constant value of omega across the tree.
E. coli LacI. Orthologs of E. coli LacI were retrieved by a
BLASTP search of the UniProt database, and choosing the top
hits that sampled the bacterial clades useful for reconstructing
ancestral residues. Included were several clades of enterobacteria,
two clades of gamma-proteobacteria, and two actinobacteria as
outgroups. A phylogenetic tree (Figure S1) was inferred using the
Neighbor-Joining algorithm [28]. Ancestral sequences in the LacI
family were determined using the aaml program within PAML as
described above for the MTHFR family.
Results
Measuring Enzyme Function by Quantitative
Complementation
We have previously shown that human MTHFR enzyme
activity can be accurately measured in a simple yeast cell growth
assay whereby expression of the human enzyme (or enzyme
variant) is asked to complement the methionine biosynthetic defect
of yeast MTHFR deletions (met13). Thus, by identifying enzyme
variants that are incapable of fully restoring growth in media
lacking methionine (relative to wild-type MTHFR), we have
identified naturally occurring nonsynonymous polymorphisms that
impair enzyme function [21]. To allow quantitative comparisons
between variants in this assay, we derived a growth-rate metric by
Figure 1. Example growth curves from which rate metrics were
calculated. Shown are two examples (major MTHFR allele (open
triangle); Y189H substitution variant (closed circle)) where growth in
liquid culture was tracked over time, according to Methods. The upper
panel shows absorbance (OD595) values and the lower panel shows the
log10 transformation of the same absorbance reads. Log10-transformed
data were used to calculate maximum slopes that served as growth-rate
metrics.
doi:10.1371/journal.pgen.1000968.g001
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curve data (Figure 1). In general, growth rates measured in this
manner are directly reflective of the cellular activity of the variant
assayed [21].
Intracellular folate levels can remedy defective alleles of
MTHFR in humans and this behavior can be recapitulated in
the yeast assay [21]. While this is attractive from a therapeutic
perspective, this suppression may confound functional assessment
of mutant alleles since high folate supplementation can mask
enzymatic defects. To avoid this, cultures were supplemented with
a level of folate that was mildly rate-limiting for growth (25 ug/ml
folinic acid), which allows subtle changes in MTHFR activity to be
reflected in the growth readout [21]. Under these conditions, the
growth rate driven by the major human allele is approximately
91% of that when folate is not rate-limiting (data not shown). The
activities of the complete collection of 36 variants were assayed in
this way (Figure 2; raw replicate data for these experiments is in
Table S1).
Evolutionary Validation of Cell-Based Functional
Determinations: Expected Behaviors of Highly Conserved
Sites and a Reconstructed Recent Ancestor
As described in Methods, we used the unchanged major allele of
MTHFR (wild type) as a positive control and the impaired A222V
allele as a negative control to define growth-rate boundaries for
distinguishing functional from impaired variants. Although the
A222V variant is not a complete loss-of-function allele, it was
chosen as a negative control to effectively set the threshold of
activity that distinguishes functional from impaired variants. This
change has been well documented to cause a 50% loss in intrinsic
activity [16,22] that, importantly, can lead to metabolic dysfunc-
tion and thus would be subject to selective pressures. Even so, this
variant has reached a high frequency in the human population
(,30% global frequency; http://www.ncbi.nlm.nih.gov/SNP/
snp_ref.cgi?rs=1801133). Thus, selective pressures against this
allele must be minimal and this level of activity is likely to be near
the borderline of impairment, unless there is some undetected
heterozygote advantage.
To establish that the assay and this classification scheme can
reliably distinguish functional from impaired variants of MTHFR,
and that, at least in straightforward cases, analysis of orthologs
accurately predicts whether a given variant will be functional or
impaired, we first tested the major human MTHFR allele and a 9-
site mutant that ‘‘resurrects’’ the human-macaque ancestral
MTHFR (S9G, L53M, Y89F, R132C, I496V, V578I, R594Q,
T639A A650E). As expected, we found both human MTHFR and
the putative human-macaque ancestral MTHFR to complement
the yeast met13 defect with approximately the same, relatively high
level of activity (Figure 2). On the other hand, the A222V
substitution resulted in significantly reduced activity. We previ-
ously demonstrated this allele is defective in this assay [21] and
demonstrate here that the quantitative growth defect (rate metric
=0.022 for A222V vs. 0.0497 for the major MTHFR allele) was in
good agreement with the reduced level of activity.
We subsequently constructed four single-site mutants of
MTHFR that each alter a site that is highly conserved in nearly
all orthologs and, thus, were expected to be functionally impaired
(see Table S2 for sequence alignments at all sites interrogated in
this study). For example, P67V substitutes a chemically very
dissimilar amino acid at a site that is conserved among all known
eukaryotic (and some prokaryotic) orthologs of human MTHFR
and, as expected, was classified as impaired (rate metric =0.02).
D291N targets an aspartic acid residue present in nearly all
eukaryotes and despite the chemical similarity of aspartate and
asparagine, the D291N variant was severely impaired (rate metric
=0.002). Lastly, we tested two different substitutions of R134, a
site at which no single amino acid is highly conserved, but at which
only polar amino acids are observed across nearly all MTHFR
orthologs (see Figure 3). R134C and R134F each substitute a
hydrophobic amino acid and each result in a drastically impaired
enzyme (both rate metrics =0). This is consistent with the
prediction that negative selection against hydrophobic amino acids
had occurred at this site, even though the identity is not strictly
conserved. These examples confirm that our assay is capable of
distinguishing between functional and impaired variants, and that,
at least in very straightforward cases, evolutionary conservation
among orthologs can also make this distinction.
Figure 2. Activities of MTHR mutants. The average maximum slope (growth-rate metric) and standard deviation for each of the 36 MTHFR
variants tested as in Methods. Replicate sets (N=5) were compared against a positive control (major MTHFR allele) and a negative control (A222V
allele) using 2 different statistical criteria as described in Methods. Green circles indicate changes not significantly different from the positive control
and significantly better than the A222V control and indicate functionality. Red squares indicate changes significantly less active than the positive
control and not significantly better than the A222V control and indicate impaired alleles. Pink triangles are classified as equivocal due to
disagreement in the statistical methods. The raw replicate data and statistical metrics are in Table S1.
doi:10.1371/journal.pgen.1000968.g002
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Orthologs of Human MTHFR
We then selected 30 additional site-specific mutants to
interrogate, based on an alignment of orthologs of human
MTHFR. Each of the 30 sites was conserved among primates,
but diverged to varying degrees in more distant lineages/species.
Furthermore, at these sites we introduced substitutions that were
accepted in at least one known ortholog (Table 1). We reasoned
that these would be relatively difficult cases for prediction methods
since this set represents sites that are both partially conserved and
partially divergent and little is known how to balance these signals.
From a practical standpoint, we limited our changes to the
catalytic domain of MTHFR, which comprises the N-terminal half
of the 656 amino acid protein (NCBI protein reference
NP_005958). This region is more prone to deleterious changes
[21,22] and most mutations that result in severe clinical
phenotypes occur in the catalytic domain (http://www.hgmd.cf.
ac.uk). In addition, although all genes shown in the phylogenetic
tree (Figure 3) are orthologous to human MTHFR by the
definition of Fitch [29], we did not choose amino acids accepted in
insect orthologs. The insect lineage appears to have an accelerated
evolutionary rate and has lost the C-terminal regulatory domain
found in other eukaryotes, thus their functional orthology is
questionable. Furthermore, we distinguished between the ortho-
logs resulting from the gene duplication event in fungi as belonging
to either the Met13 group (defined by S. cerevisiae Met13) or the
Figure 3. Phylogenetic tree and ancestral allele determination from orthologs of human MTHFR. Tree: MTHFR sequences from modern-
day species are indicated. Database identifiers for these entries are listed in Table S2. Gene duplication events are shown with orange circles, and
speciation events with green circles. Nodes numbered in red correspond to ancestral branch points in the human MTHFR lineage. Longer branch
lengths indicate faster evolutionary rate. The chicken sequence was given an arbitrary, long branch length because it is a sequence fragment and the
actual branch length could not be accurately determined. Ancestral allele determinations: The right columns show the amino acids found in the
modern-day sequences corresponding to positions 134, 240 and 294 in human MTHFR. These are shown to illustrate how ancestral sites are
determined and, consequently, how long the identity of the site in the human enzyme has been preserved in the human lineage (see text for details).
doi:10.1371/journal.pgen.1000968.g003
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cerevisiae and S. pombe suggests that the Met13 group of enzymes
may be functionally more similar to human MTHFR than those in
the Met12 group, which have diverged to a slightly greater degree
[30,31].
According to our functional definition, 21 mutants in this set of
30 had impaired activity, 5 were functional, and 4 were equivocal
(Figure 2). The relatively large number of impaired mutants was
unexpected given the results of computational prediction methods.
For example, the SIFT (Sorting Intolerant From Tolerant)
Table 1. Amino acid substitutions from human MTHFR orthologs tested for functional impact.
Change* Human Site Conserved in Clade Substitution Accepted in Ortholog**
Human Lineage
Preservation***
Grantham
score
SIFT
score
Y119Q Deuterostomes, Nematodes, N. crassa A. nidulans, A. niger (Met12 group) Bilaterian 99 0.21
R134S P. troglodytes, M. musculus B. taurus, C. familiaris Rodent-Primate 110 0.66
Y174R Deuterostomes, Fungi, D. discoideum,
Bacteria
C. elegans, C. briggsae Unikont 77 0.12
E300H Amniotes, Nematodes, Fungi S. purpuratus, A. thaliana Tetrapod 40 0.24
E203Q Vertebrates, Fungi, Bacteria C. elegans, C. briggsae Vertebrate 29 0.11
I77R Chordates N. crassa, B. fuckeliana (Met12 group) Vertebrate 97 0.1
M110I Deuterostomes, L. major S. pombe (Met12 group) Deuterostome 10 0.19
R295Q Deuterostomes, Fungi C. elegans, C. briggsae Deuterostome 54 0.06
P202S Deuterostomes, Nematodes,
Fungi, Plants, Bacteria
D. discoideum, S. pombe (Met13 group) Last Universal 74 0.08
Q267S Chordates S. purpuratus Chordate/Last Universal
# 80 0.02
D223N All Clades C. elegans, C. briggsae Last Universal 23 0.13
I294V Deuterostomes C. elegans, C. briggsae Deuterostome/Last Universal
# 29 1
Q267R Chordates C. elegans, C. briggsae Chordate/Last Universal
# 54 1
N152S Deuterostomes, Fungi, Bacteria C. elegans, C. briggsae Last Universal 46 0.04
W165F Deuterostomes, Fungi, Bacteria A. thaliana, O. sativa Unikont 40 0.3
F237L Placental Mammals G. gallus, X. tropicalis Mammalian/Eukaryote
# 22 1
E123T Vertebrates, Fungi, Plants, D.discoideum A. nidulans, N. crassa (Met12 group) Vertebrate 65 0.16
Y189H Vertebrates, Nematodes, Fungi, Plants S. cerevisiae, A. nidulans, A. gossypii,
N. crassa (Met13 group)
Eukaryote 83 0.56
D92T Deuterostomes, Nematodes,
Fungi, Plants
S. cerevisiae, A. gossypii,
A. nidulans (Met12 group)
Eukaryote 85 0.08
A222V All Clades T. maritima, T. petrophila, Last Universal 64 0.06
S264G Bilaterians, Fungi D. discoideum, A. thaliana, O. sativa Bilaterian 56 0.41
W165E Deuterostomes, Fungi, Bacteria A. gossypii, P. pastoris (Met12 group) Unikont 152 0.11
E285V All Clades S. pombe (Met13 group) Last universal 121 0.02
T69F Deuterostomes, Fungi, Plants, Bacteria C. elegans, C. briggsae Last Universal 103 0.04
C306S Deuterostomes, Nematodes, Fungi, Plants,
Bacteria
D. discoideum, T. pseudonana Last Universal 112 0.02
V240E Deuterostomes, Nematodes, Fungi, Plants,
Bacteria
S. cerevisiae, A.gossypii,
A.nidulans, S. pombe, N. crassa
(Met12 group)
Last Universal 121 0.08
F237E Placental mammals C. elegans, C. briggsae Mammalian/Eukaryote
# 140 0.18
C306V Deuterostomes, Nematodes, Fungi, Plants,
Bacteria
A. gossypii, A. nidulans (Met12 group) Last Universal 192 0.09
G247P All Clades N. crassa, B. fuckeliana (Met12 group) Last Universal 42 0.03
L336S All Clades S. cerevisiae, S. pombe, A. gossypii
(Met12 group)
Last Universal 145 0.03
*Human-Macaque ancestral reconstruction and substitutions not found in any ortholog (P67V, R134C, R134F, D291N) are not listed.
**Boldface species are present in Figure 3.
***Ancestral reconstruction, .90% probability using PAML.
#The identities of these residues are conserved in the human lineage from the more recent of the two ancestors listed, at which point a longer-standing pattern of
preservation (dating back to the more ancient of the two) was broken.
‘‘Human Site Conserved in Clade’’ lists clades in which the identity of the human enzyme is seen multiple times. The sequence alignments for all positions interrogated
in this study are in Table S2. ‘‘Human Lineage Preservation’’ is the most ancient MTHFR ancestor in which the identity of that site in the human enzyme has been
preserved. ‘‘Substitution accepted in Ortholog’’: MTHFR ortholog(s) in which the substitution can be found. Grantham score [5] estimates the physico-chemical dis-
similarity between the parent and substituting amino acids. SIFT score [32] estimates whether the amino acid change can be tolerated based on the variability at that
site in homologous proteins (see text for details). The order is presented as in Figure 2.
doi:10.1371/journal.pgen.1000968.t001
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using the recommended 0.05 score threshold (T69F, N152S,
G247P, Q267S, E285V, C306S, L336S; Table 1). SIFT calculates
a score for each mutant based on the substitutions observed at a
given site across a set of homologous proteins. Like most existing
methods that incorporate homology as a predictive parameter,
SIFT assumes that orthologs are evolving under similar evolu-
tionary constraints. Since all of our substitutions appear in an
ortholog of human MTHFR, it is not surprising that SIFT’s
predictions are strongly biased toward functional substitutions.
Concordant with this view, a second commonly used predictive
algorithm, Pmut [12], also predicted 80% of these substitutions to
be functional (data not shown). Since most changes were accepted
in more than one closely related ortholog (Table 1), it is unlikely
that the data is skewed by infrequent alleles or spurious mutation
in the individual MTHFR genes sequenced.
SIFT displayed only 42% accuracy in discriminating functional
from impaired MTHFR alleles when considering only those
changes unambiguously classified as functional or impaired in the
yeast assay (i.e. ignoring the 4 equivocal calls in this 30 mutation
set; Figure 4A). Since all functional alleles had a SIFT score
.=0.09, a threshold empirically set at this point (rather than the
0.05 recommended) would have increased overall accuracy to
62%. However, even this threshold would have still resulted in
significant over-prediction of functional alleles (Figure 4A).
We next assessed a completely different distance metric than
evolutionary conservation. The Grantham score provides a
measure of the physico-chemical dis-similarity between any pair
of amino acids [5]. This measure was evaluated against the
observed growth rates for each of these 30 mutations (Figure 4B).
Consistent with previous results [4], there was a significant
negative correlation (R=20.48, Pval=0.007), indicating that, on
average, the larger the physico-chemical difference between the
wild-type and substituting amino acid, the greater the functional
impairment. However, despite this correlation, the Grantham
differences were not very useful for discriminating functional from
impaired mutations: even a threshold optimized for our dataset
yields an accuracy of only 42% (Figure 4B). Similarly to SIFT,
such a stratification of the data would have led to an over-
prediction of functional alleles. Thus, neither of these tools, which
analyze and estimate the impact of amino acid substitution in very
different ways, appeared particularly accurate on this dataset.
Figure 4. Accuracy of discrimination between functional and impaired variants by different methods. Growth-rate metrics for the 30
variants in Table 1 plotted against scores/classifications from various methods that estimate functional impact. The accuracy of each method was
determined by calculating the number of mutations correctly called as functional or impaired divided by the number of mutations unambiguously
classified by experimental data. Binning of mutations was determined by using a threshold empirically defined by the functional alleles (dashed
vertical line in each panel) to define the functional (left of line) and impaired (right of line) bins. (A) SIFT score; note that the graph plots (1–score) to
facilitate comparison with the other methods. All functional variants have a SIFT score .0.09 which, when used as a threshold results in a
classification accuracy of 62%. The recommended threshold of 0.05 (solid vertical line) results in a lower classification accuracy (42%). (B) Grantham
scale of amino acid dissimilarity between wild-type and substituted amino acid. (C) Ancestral Site Preservation (ASP) measure, using inferred ancestral
sequences of human MTHFR. Numbers on the x-axis correspond to increasingly ancient ancestors of human MTHFR as defined by the nodes in
Figure 3. (D) Ancestral Site Preservation Extended (ASPext) measure. If a site was preserved in the ancestral lineage for a long period before being
substituted by the current-day amino acid, the more ancient ancestor is used to define preservation at this site. The preservation measure for 5
variants is shifted by this criterion (see Table 1).
doi:10.1371/journal.pgen.1000968.g004
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MTHFR: the Ancestral Site Preservation (ASP) Measure
Our finding that most of the mutants we tested were impaired,
despite the presence of these substitutions in an orthologous
protein, suggests that in these cases the site is not under the same
selective constraint in human MTHFR as it is in the ortholog. In
other words, selective constraints on a given site may differ
between lineages in the phylogenetic tree. Therefore it may be
more relevant to infer selective constraints by considering only the
direct ancestral lineage of a given protein, rather than all lineages (as in
methodologies such as SIFT that consider homologous sequences
from other organisms). We therefore defined a measure (Ancestral
Site Preservation or ASP) that is determined by the most distant
ancestor in which a given site is preserved. To determine this, we
first constructed a phylogenetic tree for the family and inferred
ancestral sequences at specific nodes in the tree (Figure 3). We
then traced back among the direct ancestors of the current-day
sequences to infer how long a given amino acid had been
preserved at a particular site. The ASP score is simply the (relative)
number of the most ancient ancestor in which the identity of the
site in human MTHFR is still preserved.
To illustrate this ASP score, Figure 3 provides examples of allele
determinations in human MTHFR ancestors at three instructive
positions in the human enzyme. Site 134 aligns an arginine (R) in
human, chimp and mouse MTHFR and, thus, is inferred to be
present in the rodent-primate ancestor (node #1 on tree).
However, because no other orthologs align R at this position,
we cannot infer the ancestral preservation prior to node #1, and
the ASP score =1. The valine (V) at position 240, on the other
hand, is extremely well-preserved in ancestors of human MTHFR.
V is inferred to be present in the placental mammal ancestor (node
#2 on tree) since all descendants align a V at that position.
Furthermore, from analyzing increasingly distant outgroups from
this node, the presence of a V in vertebrates (zebrafish),
deuterostomes (sea urchin, sea squirt), worms and insects strongly
suggests the presence of a V back to the bilaterian ancestor (node
#7). Analysis of even more distant outgroups shows that V is also
aligned at this position in several fungal orthologs, plants,
Leishmania, Dictyostelium and several distant bacterial species. The
most parsimonious inference, therefore, is that V240 is preserved
in all ancestors of human MTHFR back to the LUCA (node #10),
giving an ASP score of 10. The third example, position 294,
reveals an interesting preservation pattern whereby preservation of
isoleucine (I) from a relatively recent ancestor (inferred from the I
present in all deuterostome species) broke a longer-standing
pattern of ancestral preservation (V is inferred to be present in all
more ancient human ancestors: bilaterian through LUCA; nodes
7–10).
For our set of mutants, we found that if the identity of the site
was strictly preserved from at least as far back as the Most Recent
Common Ancestor (MRCA) of all eukaryotic MTHFRs (node #9,
Figure 3), a mutation at that site impaired human MTHFR. On
the other hand, all benign changes that resulted in a functional
enzyme were at sites whose identity was preserved from no further
than the MRCA of all unikont MTHFRs (node #8 in Figure 3).
Thus, the unikont MTHFR ancestor empirically defined the
functional threshold for the ASP measure (Figure 4C). The ASP
measure showed an accuracy of 65% among all unambiguously
classified changes and performed as well or better than Grantham
scores or SIFT for predicting functional and impaired variants in
this dataset.
Furthermore, we observed that five impaired mutants that were
mispredicted by ASP (F237L, F237E, Q267R, Q267S, I294V)
occurred at 3 positions with a very particular pattern of ancestral
preservation in which one amino acid was strictly preserved
beginning with the eukaryotic MRCA or LUCA, and substituted
only once after that. This is a very interesting pattern in light of
our results and one that is not common across MTHFR sites in
general. As mentioned above, isoleucine (I) 294 in human
MTHFR is an instructive example (Figure 3). Valine is strictly
preserved at this site in the human lineage beginning with the
LUCA, though it does diverge in some other lineages (e.g. L.
major). This strongly suggests the site was under selective constraint
in the ancient ancestors of human MTHFR. However, this site
was fixed as isoleucine beginning with the MRCA of all
deuterostome MTHFRs, suggesting that this ancestral constraint
had changed in the deuterostome MTHFR lineage, possibly due
to positive selection. Indeed, a reversion to the ancestral amino
acid, I294V in human MTHFR, resulted in a significant
impairment of function (Figure 2). Likewise at position 267,
glutamine (Q) in the human enzyme is preserved since the
chordate common ancestor, which broke the long-standing
preservation of arginine (R) at this site since the LUCA (Table 1;
see Table S2 for alignment). At position 237, phenylalanine (F) is
preserved since the placental mammal ancestor, which broke the
long-standing preservation of leucine (L) from the eukaryote
MRCA. As for I294V, changes reverting to the more ancient
amino acid (Q267R and F237L) impaired human MTHFR, even
though L237 is accepted in the recently diverged chicken ortholog
(Table 1, Figure 2).
The pattern whereby a long-standing ancestral preservation is
broken only once by a more recent ancestor in the human lineage
indicates that such positions have been under selective constraint
for long periods of time and that these constraints changed during
evolution of the lineage. If so, these sites are likely to be more
sensitive to substitutions even though the site in the human
enzyme has been preserved from only a relatively recent ancestor.
Thus, to capture the importance of such sites, we further define the
Ancestral Site Preservation Extended measure (ASPext). The ASPext is
similar to the ASP but traces back to an earlier ancestor if there
was a previous long-standing (eukaryotic MRCA or earlier) strict
preservation at that site. ASPext significantly improves the ability to
predict functional impairment among our set of MTHFR mutants
(85% accuracy; Figure 4D).
Generalizing ASP and ASPext to Other Proteins: Predicting
Functional and Impaired Mutants of LacI
To determine if the ASP would be a useful measure for
predicting functional and impaired variants more generally, we
tested its predictive ability against the extensive E. coli lac repressor
(LacI) substitution dataset [33,34]. LacI is a standard test-case for
prediction algorithms because it contains nearly comprehensive
substitution data: the functional impact of 12–13 nonsynonymous
mutants at each of 328 sites in the LacI protein was determined by
in vivo assay. Furthermore, this data set, comprising a total of 4041
single-site mutations, was used as a training set for the SIFT
algorithm [35], so SIFT has been optimized to perform on these
data. We reasoned that if ASP could perform well on LacI
predictions, despite not being optimized for this specific data set,
this would be good evidence of its more general utility. We would
not necessarily expect ASP to perform as well as SIFT, simply
because ASP makes relatively crude predictions: a site is predicted
to be either completely tolerant (all mutations are predicted to be
functional) or completely intolerant (all mutations are predicted to
be impaired). On the other hand, SIFT can predict different
outcomes for different amino acids at each site.
We were somewhat surprised, then, to find that both ASP and
ASPext actually out-performed SIFT on predictions of LacI
Ancestral Alleles Inform Mutation Prediction
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tree for LacI in bacterial species and inferred the ancestral
identities of amino acids at divergence points in the tree, as we did
for MTHFR (Figure S1). As described above, we empirically
defined the common ancestor to unikonts as the ‘‘threshold
ancestor’’ for stratifying functional and impaired alleles of
MTHFR: all benign changes were at sites preserved for this
length of time or less. Interestingly, the prokaryotic threshold
ancestor that yielded the highest prediction accuracy was the
common ancestor of LacI proteins in E. coli and Enterobacter
cancerogenus. LacI proteins in these two species share 52% identity,
which is approximately the same overall divergence as between
human MTHFR and its D. discoideum ortholog (48%) which both
share the unikont ancestor (Figure 3). This suggests a simple
method for setting a general threshold across different domains of
life.
As shown in Table 2, the accuracy of both ASP and ASPext was
72% when each substitution in LacI is simply classified as
functional (wild-type levels) or impaired (less than wild-type levels),
as is commonly done [9,11,35]. There was no difference in
performance between ASP and ASPext as only 4 sites differed
between the two methods. The 72% accuracy rate exceeds the best
prediction accuracy, to our knowledge, previously reported on the
LacI test set (70.7%), obtained by the MAPP method (Multivariate
Analysis of Protein Polymorphism; 11) trained on LacI and five of
its orthologs. Interestingly, MAPP reportedly performed worse
(69.2%) when trained using the full set of 55 LacI homologs, which
included numerous putative paralogs. Thus, restricting the
training set to a few orthologs minimizes the opportunity for
divergence of selective constraints in different lineages, which is
consistent with our findings for MTHFR.
Discussion
Most algorithms for the functional prediction of amino acid
substitution assume that divergent lineages share the same selective
constraints on homologous sites. However, we observed that
replacing a single amino acid in the human MTHFR enzyme with
one that was accepted in an orthologous protein frequently
resulted in functional impairment. Indeed, we observed that even
a substitution from a very recently diverged ortholog (F237L,
which is fixed in chicken MTHFR) resulted in significant
functional impairment. These results suggested that selective
constraints can vary in divergent lineages and do not necessarily
reflect those directing evolution of the human enzyme.
Our results are in agreement with previous studies that suggest
that the selective constraints on homologous sites may differ
substantially among orthologous proteins. There are several
reasons that selective constraints may differ between lineages,
including changes in the strength (from differences in population
dynamics that arise from the inability of selection to remove
weakly deleterious mutations from a smaller population) or even
the direction of selection (e.g. from differences in gene essentiality
for different organisms; [36]). However, several studies have
concluded that the most likely reason is compensatory mutations,
i.e. the change in selective constraints on a given site is actually due
to mutations at other sites in the same (or possibly another)
protein. Kondrashov et al. [37] estimated that about 10% of all
amino acid substitutions producing a pathogenic phenotype in
humans are present as the wild-type amino acid in at least one
mammalian ortholog. The authors termed these types of
substitutions ‘‘compensated pathogenic deviations’’ and suggested
that they were tolerated in the orthologous protein because of
second-site compensatory mutations. In support of this hypothesis,
Gao and Zhang [38] provided evidence that compensatory
mutations are the most likely explanation for the majority of
human disease mutations fixed in mice. Kulathinal et al. [39]
found that debilitating missense mutations in D. melanogaster were
fixed in related insect orthologs at a surprisingly high rate, and also
speculated that compensatory mutations must be co-evolving in
these lineages. Of the substitutions we tested, we found that 70%
were functionally impaired, a much greater proportion than
reported in the related studies cited above. However, it should be
noted that the majority of the substitutions we tested were from
more distant orthologs (26 of 30 substitutions were fixed in
orthologs whose MRCA with human was over 500 million years
ago). The long divergence times have provided more opportunity
for compensatory mutations to arise that alter the selective
constraints on a given site.
The term ‘‘compensatory mutation’’ may appear to suggest that
chronologically a second mutation occurred that ‘‘compensates’’
for a pre-existing deleterious mutation. In fact, the compensatory
mutation most likely arises first as a ‘‘pre-adaptation’’ that enables
a mutation that would otherwise have been deleterious. Thus, our
findings are consistent with the importance of evolutionary
trajectory in determining which substitutions are permissable at
any given point during evolution. For example, using ancestral
protein reconstruction, Zhang and Rosenberg [40] identified two
amino acid substitutions that contributed to the evolutionary
enhancement of RNase activity of EDN, an eosinophil-associated
RNase of primates. Each substitution individually was neutral or
perhaps only mildly deleterious to ancestral function, but in
combination were complementary in the evolution of a derived,
modified function. Likewise, neutral substitutions at some sites in
the mineralocorticoid receptor were found to be critical for
enabling adaptive substitutions to occur at other sites [41]. In
addition, multiple amino acid substitutions in beta lactamase that
confer antibiotic resistance seem to arise through only a very small
fraction of available trajectories [42]. In other words, the identity
of an amino acid at one site can be influenced by the content of
other sites and these relationships may be unique to the evolution
of specific lineages. These findings highlight the importance of
previous substitutions in defining the possibilities of subsequent
mutational events.
Given these considerations, we hypothesized that selective
constraints on a site might be better estimated from only the
evolutionary trajectory of a particular protein (or gene), rather
than including substitutions among divergent lineages. This would
remove potentially confounding signals from these other lineages,
such as differences in population dynamics, adaptation to specific
environments and compensatory mutations. To test our hypoth-
Table 2. Prediction accuracy of different algorithms on the
LacI dataset.
Algorithm Accuracy Reference*
SIFT (v.1) 68.3% 35
SIFT (v.2) 68.1% 9
MAPP (including paralogs) 69.2% 11
MAPP (only orthologs) 70.7% 11
ASP 72.0% This study
ASP extended 72.0% This study
*Only studies with published prediction results on essentially all of the .4000
mutations in the LacI dataset are listed.
doi:10.1371/journal.pgen.1000968.t002
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sequences at specific nodes in the tree for the MTHFR family as
well as the bacterial LacI family. We could then trace back among
the direct ancestors of the current-day sequence, to infer how long
a given amino acid had been preserved at a particular site, which
we dubbed the Ancestral Site Preservation (ASP) measure. In
support of our hypothesis, we found that sites that are preserved
for long periods of time in the human lineage (high ASP) will not
tolerate substitution, even though such substitutions are tolerated
in at least one orthologous protein. In addition, the ASP metric
discriminated between functional and impaired variants in both
human MTHFR and E. coli LacI (using a comparable threshold in
both cases) more accurately than any method reported to date.
This was surprising given that the ASP does not consider the
nature of the specific amino acid substitution, but rather only the
ancestry of a particular site in the protein. This suggests that, to a
reasonable approximation, most sites within a protein are either
intolerant or tolerant with respect to a wide variety of mutations,
and that intolerant and tolerant sites can be discriminated quite
well using the evolutionary history of substitution at each site. It is
also perhaps somewhat surprising that the ancestral preservation
must be for a very long time before it can be considered to be
reliably indicative of negative selection against variant amino
acids. In MTHFR, all substitutions we tested at sites preserved
since at least the eukaryotic common ancestor (approximately
1500 million years ago), undoubtedly due to selection against
variant amino acids, resulted in a nonfunctional protein by our
definition. However, when preservation has occurred for shorter
periods of time, most mutations we tested had no significant
functional impact in our assay, suggesting that in MTHFR
ancestral preservation even for many hundreds of millions of years
may be due in part to random chance rather than selection.
For MTHFR we found that a modified measure, which we
dubbed ‘‘ASP extended’’ (ASPext), improved the quality of
predictions by accounting for sites that had been preserved for
long periods of time during the history of MTHFR, but then
changed relatively recently. These are examples of changed
evolutionary constraints within the human lineage and, as
discussed above for extant orthologous proteins, are most likely
due to compensatory mutations. ASPext is capable of highlighting
substitutions fixed by recent positive selection in the human
lineage (which has been suggested; [36,43]), if they occurred at
previously preserved sites.
Thus, we conclude that as orthologs diverge from their most
recent common ancestor, their different evolutionary trajectories
lead to the divergence in the selective constraints on homologous
sites. While lineage-specific adaptive selection and variable
strength of purifying selection contribute to such divergence of
constraints, the accumulation of potentially compensatory neutral
(or near-neutral) substitutions underlie and enable lineage-specific
trajectories. In support of this conclusion, Kondrashov et al. [44]
have recently shown that the continued sequence divergence
observed for distant orthologs is inconsistent with a model of
lineage-independent selective constraints on homologous sites.
In this study we defined preservation strictly in that only the
identity of the amino acid at a particular site was considered in
determining the ASP. Of course, this definition could be relaxed to
include chemically similar amino acids. As we discussed above,
there seemed to be a strict requirement for a polar amino acid at
position 134 in human MTHFR, although the identity of this site
(arginine) is preserved back to only the rodent-primate ancestor.
Thus, using polarity as the preservation feature rather than
identity would yield a much larger ASP score and may be more
informative for changes such as R134F and R134C which are not
polar and are quite debilitating. In this case, the R134S change,
which was functional, would still be predicted to be functional
because it does not break the polarity preservation.
These observations have implications for understanding and
reconstructing protein evolution, as well as improving the accuracy
of predicting the effects of amino acids substitution on human
protein function. The ASP measure appeared to have advantages
over other comparative sequence approaches in using phylogeny
to predict functionality, though it remains clear that physico-
chemical constraints on substitution also play a role. Use of our
basic approach should prevent distinct historical constraints from
confounding inferences about physico-chemical constraint, and
reveal how to better incorporate both ancestral preservation and
physico-chemical differences into functional prediction. Perhaps
most importantly, by enabling more accurate computational
predictions of functional polymorphisms in humans, our results
should aid epidemiological efforts in identifying the genetic
deficiencies that are etiological for disease.
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Figure S1 Phylogenetic tree of bacterial orthologs of the Lac
repressor (LacI). UniProt identifiers and species are listed.
ARTS2=Arthrobacter, strain FB24 (actinobacteria); STRCO=
Streptomyces coelicolor (actinobacteria); PSEU2=Pseudomonas
syringae (gamma-proteobacteria); HAEIN=Haemophilus influenzae
(gamma-proteobacteria); YERPE=Yersinia pestis (enterobacteria);
9ENTR=Enterobacter cancerogenus (enterobacteria); CITRO=
Citrobacter sp. 30_2 (enterobacteria); SALAR Salmonella arizonae
(enterobacteria); ECOLI=Escherichia coli K12 (enterobacteria);
ECO7I=Escherichia coli O7:K1 (enterobacteria). Arrow indicates
the common ancestor between E. coli and Enterobacter and was used
as the ancestral threshold for predicting functional or impaired
alleles.
Found at: doi:10.1371/journal.pgen.1000968.s001 (0.04 MB
DOC)
Table S1 Maximum slopes for individual replicates and
statistical calculations.
Found at: doi:10.1371/journal.pgen.1000968.s002 (0.07 MB
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